Orchid Pharma Limited
NSE: ORCHPHARMA
NSE
705.15
6.05 (0.87%)
Prev Close
699.1
Open Price
700.1
Volume
37,012
Today Low / High
691.5 / 710
52 WK Low / High
603.8 / 1997.4
Range
670 - 740
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 705.15, with a change of 6.05 (0.8654%). The expected target range on the NSE is between 670 - 740. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
30 Jul
700.10
-0.28%
29 Jul
682.30
2.46%
28 Jul
710.40
-1.47%
25 Jul
715.95
-0.78%
24 Jul
725.80
-1.88%
23 Jul
726.70
-0.67%
22 Jul
723.85
0.06%
21 Jul
738.90
-2.52%
18 Jul
746.80
-1.91%
17 Jul
756.95
-2.06%
16 Jul
741.30
1.02%
15 Jul
719.00
2.91%
14 Jul
724.50
-0.61%
11 Jul
726.50
-1.13%
10 Jul
734.50
-1.57%
09 Jul
736.00
-1.01%
08 Jul
742.70
-2.25%
07 Jul
762.00
-3.01%
04 Jul
753.30
0.37%
03 Jul
724.20
3.22%
02 Jul
739.55
-2.08%
Orchid Pharma Limited Graph
Orchid Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Orchid Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 705.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 705.15 | 712.20 | 640.98 - 783.42 |
| 719.25 | 575.40 - 863.10 | ||
| 726.30 | 508.41 - 944.20 | ||
| Bearish Scenario | 705.15 | 698.10 | 628.29 - 767.91 |
| 691.05 | 552.84 - 829.26 | ||
| 684.00 | 478.80 - 889.19 |
Overview of Orchid Pharma Limited
ISIN
INE191A01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
131,797
Market Cap
35,604,808,200
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
702.57
DCF
-9
Financial Ratios Every Investor Needs
Stock Dividend of ORCHPHARMA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2012-09-13 | September 13, 12 | 3 | 0.0138 | |||
| 2011-07-19 | July 19, 11 | 3 | 0.0138 | |||
| 2010-07-12 | July 12, 10 | 10 | 0.0459 | |||
| 2009-09-17 | September 17, 09 | 1 | 0.0046 | |||
| 2008-09-18 | September 18, 08 | 3 | 0.0138 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 921.93 Cr | 544.22 Cr | 377.70 Cr | 0.4097 | 0.00 Cr | 0.00 Cr | 256.80 Cr | 99.66 Cr | 19.65 | 144.65 Cr | 0.1081 |
| 2024-03-31 | 819.07 Cr | 503.18 Cr | 315.88 Cr | 0.3857 | 7.09 Cr | 8.43 Cr | 78.47 Cr | 92.17 Cr | 19.06 | 141.92 Cr | 0.1125 |
| 2023-03-31 | 665.90 Cr | 401.25 Cr | 264.64 Cr | 0.3974 | 6.36 Cr | 8.79 Cr | 29.67 Cr | 46.32 Cr | 11.35 | 142.94 Cr | 0.0696 |
| 2022-03-31 | 559.56 Cr | 327.09 Cr | 232.47 Cr | 0.4154 | 6.63 Cr | 8.90 Cr | -33.89 Cr | -1.95 Cr | -0.48 | 63.58 Cr | -0.0035 |
| 2021-03-31 | 450.06 Cr | 241.30 Cr | 208.76 Cr | 0.4638 | 4.81 Cr | 12.90 Cr | -50.49 Cr | -116.53 Cr | -28.55 | 65.87 Cr | -0.2589 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 21.11 Cr | 1,687.91 Cr | 420.63 Cr | 1,267.2854 Cr | 174.61 Cr | 153.50 Cr | 326.37 Cr | 696.41 Cr | 0.00 Cr | 0.00 Cr | 49.67 Cr | 285.5696 Cr |
| 2024-03-31 | 3.60 Cr | 1,553.87 Cr | 384.41 Cr | 1,169.4661 Cr | 135.18 Cr | 131.58 Cr | 264.23 Cr | 645.12 Cr | 0.00 Cr | 0.00 Cr | 45.84 Cr | 259.9743 Cr |
| 2023-03-31 | 22.60 Cr | 1,225.21 Cr | 536.56 Cr | 688.6490 Cr | 331.35 Cr | 308.75 Cr | 228.74 Cr | 619.17 Cr | 1.68 Cr | 0.00 Cr | 44.44 Cr | 371.8917 Cr |
| 2022-03-31 | 4.31 Cr | 1,110.56 Cr | 463.18 Cr | 647.3799 Cr | 267.95 Cr | 263.65 Cr | 172.66 Cr | 604.82 Cr | 0.00 Cr | 0.00 Cr | 45.50 Cr | 240.7783 Cr |
| 2021-03-31 | 15.69 Cr | 1,237.25 Cr | 584.34 Cr | 652.9078 Cr | 452.74 Cr | 437.05 Cr | 152.89 Cr | 677.51 Cr | 0.04 Cr | 0.00 Cr | 0.42 Cr | 142.0818 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.2151 Cr | -26.9309 Cr | 25.2217 Cr | -130.8929 Cr | 17.5059 Cr | 21.1068 Cr | -150.1080 Cr | 99.4633 Cr | 28.3351 Cr | 0.0000 Cr | -62.1454 Cr |
| 2024-03-31 | 125.9920 Cr | -312.0286 Cr | 167.0404 Cr | 61.1772 Cr | -18.9962 Cr | 3.6009 Cr | -64.8148 Cr | 92.1665 Cr | -208.5472 Cr | 0.0000 Cr | -35.4881 Cr |
| 2023-03-31 | 18.3380 Cr | -31.2139 Cr | 31.1664 Cr | -66.5751 Cr | 18.2905 Cr | 22.5971 Cr | -84.9131 Cr | 46.3183 Cr | 63.3921 Cr | 0.0000 Cr | -56.0817 Cr |
| 2022-03-31 | 92.4746 Cr | 112.9362 Cr | -216.7981 Cr | 78.0711 Cr | -11.3873 Cr | 4.3066 Cr | -14.4035 Cr | -1.9512 Cr | -184.7864 Cr | 0.0000 Cr | 2.5369 Cr |
| 2021-03-31 | 23.5860 Cr | 67.2051 Cr | -164.9887 Cr | 22.9820 Cr | -74.1976 Cr | 15.6939 Cr | -0.6040 Cr | -116.5300 Cr | -125.0800 Cr | 0.0000 Cr | -33.4985 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 237.48 Cr | 138.02 Cr | 99.46 Cr | 0.4188 | 68.35 Cr | 22.29 Cr | 4.40 | 31.88 Cr | 0.0939 |
| 2024-12-31 | 217.34 Cr | 124.79 Cr | 92.55 Cr | 0.4258 | 61.89 Cr | 20.78 Cr | 4.10 | 34.85 Cr | 0.0956 |
| 2024-09-30 | 222.70 Cr | 131.16 Cr | 91.54 Cr | 0.4110 | 21.71 Cr | 27.24 Cr | 5.37 | 37.85 Cr | 0.1223 |
| 2024-06-30 | 244.41 Cr | 150.25 Cr | 94.15 Cr | 0.3852 | 24.05 Cr | 29.35 Cr | 5.79 | 40.06 Cr | 0.1201 |
| 2024-03-31 | 217.10 Cr | 146.85 Cr | 70.26 Cr | 0.3236 | 20.50 Cr | 33.53 Cr | 6.81 | 42.28 Cr | 0.1544 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 21.11 Cr | 161.57 Cr | 182.68 Cr | 241.83 Cr | 326.37 Cr | 807.42 Cr | 696.41 Cr | 1,687.91 Cr | 420.63 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 243.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,224.24 Cr |
| 2024-09-30 | 4.35 Cr | 243.59 Cr | 247.94 Cr | 215.20 Cr | 320.58 Cr | 833.37 Cr | 656.15 Cr | 1,635.14 Cr | 410.90 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 3.62 Cr | 0.00 Cr | 0.00 Cr | 3.62 Cr | 0.00 Cr | 0.00 Cr | -1,169.47 Cr |
| 2024-03-31 | 3.60 Cr | 0.01 Cr | 4.52 Cr | 200.35 Cr | 264.23 Cr | 790.75 Cr | 645.12 Cr | 1,553.87 Cr | 384.41 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 20.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 27.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 29.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 33.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 29.43 Cr | 18.54 Cr | 0.00 Cr | 0.00 Cr | 18.54 Cr | 68.90 Cr | 50.36 Cr | 0.00 Cr | 18.54 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2019-07-25 | July 25, 19 | 1:218 |
| 2005-09-15 | September 15, 05 | 3:2 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,733.80 | ₹4,159,871,664,000.00 | ₹2,318,664.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,650.00 | ₹1,765,368,850,000.00 | ₹226,973.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,730.60 | ₹1,262,602,917,000.00 | ₹439,520.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,292.10 | ₹1,075,456,274,108.00 | ₹1,386,961.00 |
| Mankind Pharma Limited | MANKIND | ₹2,575.50 | ₹1,062,982,921,380.00 | ₹763,328.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹995.15 | ₹1,001,349,784,500.00 | ₹775,382.00 |
| Lupin Limited | LUPIN | ₹1,984.60 | ₹906,460,096,200.00 | ₹754,124.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,158.00 | ₹672,568,716,000.00 | ₹672,249.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,099.60 | ₹609,733,674,000.00 | ₹69,765.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,153.60 | ₹607,748,073,600.00 | ₹786,090.00 |
| Laurus Labs Limited | LAURUSLABS | ₹881.45 | ₹475,603,095,050.00 | ₹5,551,173.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,529.50 | ₹388,040,268,000.00 | ₹501,348.00 |
| Cohance Lifesciences Limited | COHANCE | ₹997.40 | ₹381,572,333,779.00 | ₹30,739.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,800.50 | ₹349,816,056,000.00 | ₹68,739.00 |
| Piramal Enterprises Limited | PEL | ₹1,287.60 | ₹291,870,592,800.00 | ₹4,377,271.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,782.60 | ₹278,652,466,800.00 | ₹198,162.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,684.80 | ₹273,744,619,200.00 | ₹253,355.00 |
| Eris Lifesciences Limited | ERIS | ₹1,816.60 | ₹247,415,470,200.00 | ₹258,998.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,340.00 | ₹233,500,000,000.00 | ₹39,783.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹1,007.60 | ₹198,056,878,800.00 | ₹43,245.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,236.30 | ₹196,919,100,300.00 | ₹1,978,762.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,910.00 | ₹178,463,909,000.00 | ₹72,265.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹973.15 | ₹174,300,896,500.00 | ₹709,365.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,145.80 | ₹163,105,905,860.00 | ₹121,630.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹492.15 | ₹119,417,244,600.00 | ₹954,418.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,947.00 | ₹98,716,631,800.00 | ₹41,877.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹919.15 | ₹89,884,505,735.00 | ₹41,687.00 |
| Strides Pharma Science Limited | STAR | ₹945.35 | ₹87,126,008,445.00 | ₹401,712.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹946.50 | ₹85,785,667,830.00 | ₹174,284.00 |
| FDC Limited | FDC | ₹484.45 | ₹78,873,304,500.00 | ₹30,593.00 |
| Suven Life Sciences Limited | SUVEN | ₹269.30 | ₹58,727,328,200.00 | ₹85,394.00 |
| Innova Captab Limited | INNOVACAP | ₹917.50 | ₹52,503,873,275.00 | ₹36,415.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹151.93 | ₹49,304,627,460.00 | ₹195,988.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹522.25 | ₹47,665,757,500.00 | ₹446,949.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.86 | ₹44,023,913,100.00 | ₹235,318.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹619.85 | ₹43,641,035,130.00 | ₹39,695.00 |
| Hikal Limited | HIKAL | ₹329.80 | ₹40,664,669,800.00 | ₹316,649.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹404.55 | ₹40,567,464,900.00 | ₹352,761.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,405.80 | ₹39,789,526,200.00 | ₹52,499.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹705.15 | ₹35,764,573,365.00 | ₹37,012.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹59.69 | ₹32,707,374,260.00 | ₹1,444,289.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹651.90 | ₹31,390,940,700.00 | ₹124,331.00 |
| Indoco Remedies Limited | INDOCO | ₹324.50 | ₹29,934,443,550.00 | ₹64,322.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹100.29 | ₹29,437,822,830.00 | ₹15,953,556.00 |
| Alembic Limited | ALEMBICLTD | ₹114.24 | ₹29,334,775,566.00 | ₹212,418.00 |
Key Executives
Head of Medico Marke
Mr. Prabhu Vinayagam
Gender: male
Year Born: 1970
Whole Time Director
Mr. Mridul Dhanuka
Gender: male
Year Born: 1980
Vice President and Unit Head of API & FDF
Dr. R. J. Sarangdhar
Gender: Not Specified
Year Born: 1964
Company Secretary & Compliance Officer
Mr. Kapil Dayya
Gender: male
Year Born:
President of API, CSR and SH & E
Mr. Sivaswami Mani
Gender: male
Year Born: 1960
Chief Executive Officer of Orchid AMS
Mr. Rajnish Rohatgi B. Tech.
Gender: male
Year Born: 1962
Head of Human Resources
Mr. Ashok Clifford D
Gender: male
Year Born: 1973
Chief Financial Officer
Mr. Sunil Kumar Gupta
Gender: male
Year Born: 1963
Head of CTD & IPM
Dr. S. Srinivasan
Gender: Not Specified
Year Born: 1971
MD & Director
Mr. Manish Dhanuka
Gender: male
Year Born: 1967
FAQs about Orchid Pharma Limited
Who is the CEO of the company?
The CEO is Rajnish Rohatgi B. Tech..
What is the current market price of the stock?
The current price is ₹702.00.
What is the 52-week price range?
The range is ₹603.8-1997.4.
What is the market capitalization of the company?
The market capitalization is ₹3,560.48 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 35.73.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Orchid Pharma Limited (ISIN: INE191A01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,560.48 crores and an average daily volume of 131,797 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.